Nurul Ain Nasim Mohd Yusof1*, Khairul Akmal Abdul Rahman1, Ulfatul Khusna Samuri1, Shaik Ahmad Kamal Shaik Fakiruddin1, Zulaiha Muda2, Tan Jun Jie3, Fatin Fazrina Roslan4, Adiratna Mat Ripen5, Yuslina Mat Yusoff1
1. Hematology Unit, Cancer Research Centre, Institute for Medical Research, National Institutes of Health (NIH) Malaysia, Ministry of Health Malaysia, 40170 Shah Alam, Selangor, Malaysia
2. Tunku Azizah Hospital, 50300 Wilayah Persekutuan Kuala Lumpur, Malaysia
3. Zhejiang Tianyuan Biotechnology Co., LTD., Ningbo, Zhejiang, China
4. USM-ALPS Cardiac Research Laboratory, Advanced Medical and Dental Institute, Universiti Sains Malaysia, 11700 Penang, Malaysia.
5. Cancer Research Centre, Institute for Medical Research, National Institutes of Health (NIH) Malaysia, Ministry of Health Malaysia, 40170 Shah Alam, Selangor, Malaysia
*Corresponding author: Nurul Ain Nasim Mohd Yusof.
ABSTRACT
INTRODUCTION: Induced pluripotent stem cells (iPSCs) are invaluable tools for modelling genetic diseases and hold great promise as cell sources for future clinical therapies. This technology offers an ethically acceptable and immunologically compatible alternative to embryonic stem cells, aligning with the core principles of personalised medicine. However, the need for invasive tissue sampling limits donor participation for iPSC generation. Additionally, the use of integrating transgenes raises concerns due to potential random insertion into the genome, which may lead to oncogenic effects.
OBJECTIVE(S): This study aims to establish an efficient, integration-free, and feeder-free protocol for generating iPSC lines from peripheral blood mononuclear cells (PBMCs). This minimally invasive approach offers a practical alternative to invasive somatic sources such as skin biopsies.
MATERIALS & METHODS: PBMCs were freshly isolated from healthy donors using CPT™ tubes and processed under sterile conditions following negative screening for HIV, Hepatitis B, and Hepatitis C. Cells were cultured in expansion medium and reprogrammed using non-viral plasmids encoding Yamanaka factors, introduced via Neon™ NxT electroporation system. Post-electroporation, reprogrammed cells were maintained in a feeder-free culture.
RESULTS: Colonies with typical embryonic stem cell-like morphology emerged within two to three weeks. Early assessments based on colony morphology and proliferation patterns indicate successful reprogramming. Further validation through the expression of pluripotency markers (OCT4, SOX2, NANOG) and tri-lineage differentiation assays is currently ongoing.
CONCLUSION: This study has successfully established a reproducible, non-integrative, and feeder-free method for generating iPSC lines from peripheral blood. This strategy provides a minimally invasive platform for patient-specific iPSC generation, supporting future clinical and translational research. Importantly, it lays the foundation for precision medicine applications using iPSC-based models in facilitating studies on genetic disorders, drug response variability, and personalised therapeutics tailored to local genetic diversity in Malaysia.
KEYWORDS: Induced Pluripotent Stem Cells (iPSCs), Peripheral Blood Mononuclear Cells (PBMCs), Precision Medicine, Non-Viral Reprogramming


